bioAffinity Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
CEOMaria Zannes
CEOMaria Zannes
Employees57
Employees57
HeadquartersSan Antonio, Texas
HeadquartersSan Antonio, Texas
Founded2014
Founded2014
Employees57
Employees57
BIAF Key Statistics
Market cap7.14M
Market cap7.14M
Price-Earnings ratio-0.36
Price-Earnings ratio-0.36
Dividend yield—
Dividend yield—
Average volume659.32K
Average volume659.32K
High today$0.267
High today$0.267
Low today$0.242
Low today$0.242
Open price$0.242
Open price$0.242
Volume224.09K
Volume224.09K
52 Week high$2.26
52 Week high$2.26
52 Week low$0.1639
52 Week low$0.1639
People also own
Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.